Neuren Pharmaceuticals Limited

DB:NK9 Stock Report

Market Cap: €950.4m

Neuren Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:NK9 Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
16 Aug 24Buy€60,846Joe BasileIndividual6,406€9.50
17 Jul 24Buy€81,258,921Milford Asset Management, LTDCompany8,499,600€9.56
17 Jul 24Sell€80,966,553Milford Asset Management, LTDCompany9,003,256€8.99
11 Jun 24Buy€59,925Joe BasileIndividual5,000€11.99

Insider Trading Volume

Insider Buying: NK9 insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of NK9?
Owner TypeNumber of SharesOwnership Percentage
Public Companies404,0720.316%
Individual Insiders4,235,3313.31%
Private Companies12,359,0129.67%
Institutions22,782,63817.8%
General Public88,034,62368.9%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 31.11% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
4.96%
The Vanguard Group, Inc.
6,342,212€47.2m23.6%no data
4.74%
Milford Asset Management, LTD
6,058,321€45.0m-7.68%0.98%
3.23%
Cameron Richard Pty Limited
4,123,084€30.7m0%no data
2.12%
Wilson Asset Management (International) Pty Ltd.
2,705,643€20.1m0%1.07%
2.06%
Stuart Andrew Pty. Ltd.
2,633,787€19.6m0%no data
1.95%
Norges Bank Investment Management
2,486,288€18.5m-17.5%no data
1.89%
Trevor Scott
2,414,784€18.0m0%no data
1.75%
BlackRock, Inc.
2,239,715€16.7m0.28%no data
1.46%
Smithley Super Pty. Limited
1,870,000€13.9m0%no data
1.38%
Linwierik Super Pty. Limited
1,761,385€13.1m0%no data
0.67%
BetaShares Capital Limited
853,589€6.3m12.1%0.04%
0.59%
First Colby Co Pty Ltd
750,000€5.6m0%no data
0.59%
Mjhft Pty Ltd
750,000€5.6m0%no data
0.53%
Robin Congreve
671,637€5.0m0%no data
0.41%
State Street Global Advisors, Inc.
523,829€3.9m1.54%no data
0.38%
Goldman Sachs Asset Management, L.P.
481,489€3.6m369%no data
0.37%
Emancipayte Pty ltd
470,756€3.5m0%no data
0.33%
Netwealth Investments Ltd.
421,309€3.1m0%0.04%
0.32%
He Zhao
405,000€3.0m0%no data
0.32%
Pfizer Inc.
404,072€3.0m0%no data
0.31%
Jonathan Pilcher
398,207€3.0m0%no data
0.31%
Jupiter Fund Management Plc
396,906€3.0m401%0.01%
0.21%
Patrick Donald Davies
264,634€2.0m0%no data
0.16%
Charles Schwab Investment Management, Inc.
201,087€1.5m-2.84%no data
0.1%
Nordea Investment Management, AB
130,624€971.3k0.02%no data